FORWARD PHARMA A/S: Financial statements 2024
CVR: 28865880
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233. The solvency ratio was 58.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -9,457,909
- Profit/Loss
- DKK 75,927,645
- Equity
- DKK 488,330,233
- Total Assets
- DKK 835,352,476
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9.5 mio. | 75.9 mio. | 488.3 mio. | 2 |
| 2023 | - | -6.1 mio. | -3.8 mio. | 426.4 mio. | 2 |
| 2022 | - | -11.6 mio. | -31.5 mio. | 430.4 mio. | 2 |
| 2021 | - | -10.8 mio. | -12.3 mio. | 461.9 mio. | 2 |
| 2020 | - | -7.8 mio. | -42.2 mio. | 474.1 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 4, 2024, Torsten Goesch has left the board of directors of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2023. Gross profit came to DKK -6,130,606, and the net result was DKK -3,832,516.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.